OncoVista Innovative Therapies, Inc. (OVIT)
OVIT Stock Price Chart
Explore OncoVista Innovative Therapies, Inc. interactive price chart. Choose custom timeframes to analyze OVIT price movements and trends.
OVIT Company Profile
Discover essential business fundamentals and corporate details for OncoVista Innovative Therapies, Inc. (OVIT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
26 Oct 2007
Employees
2.00
Website
https://www.oncovista.comCEO
Alexander L. Weis
Description
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.
OVIT Financial Timeline
Browse a chronological timeline of OncoVista Innovative Therapies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
OVIT Stock Performance
Access detailed OVIT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.